{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T14:17:31Z","timestamp":1794147451740,"version":"4.8.0"},"reference-count":34,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["109-2314-B-182A-009-MY2"],"award-info":[{"award-number":["109-2314-B-182A-009-MY2"]}],"id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2314-B-182A-027-"],"award-info":[{"award-number":["111-2314-B-182A-027-"]}],"id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2314-B-182-070-MY3"],"award-info":[{"award-number":["112-2314-B-182-070-MY3"]}],"id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["BMRPJ30"],"award-info":[{"award-number":["BMRPJ30"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG8N0881"],"award-info":[{"award-number":["CMRPG8N0881"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG8P0631"],"award-info":[{"award-number":["CMRPG8P0631"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CORPG8P0561"],"award-info":[{"award-number":["CORPG8P0561"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The optimal lumateperone dose for bipolar depression remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To examine its dose\u2013response relationship for efficacy and safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We systematically searched major databases to 1 July 2025. Efficacy outcomes included change in depression severity, global illness severity, quality of life, responder, and remitter rates. Safety outcomes included all-cause dropout, discontinuations due to adverse event (AE), treatment-emergent AE, mania, suicidality, extrapyramidal symptoms, body weight, lipid profile, and fasting glucose. A one-step dose\u2013response meta-analysis generated effect sizes, reported as standardized mean differences (SMDs) and risk ratios (RRs) with 95% confidence intervals (CIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Three randomized controlled trials involving 1454 patients showed that a 42-mg daily dose of lumateperone significantly improved depressive symptoms (SMD\u2009=\u2009\u22120.26; 95% CI: \u22120.51, \u22120.02), Clinical Global Impression-Bipolar-Severity (CGI-BP-S) overall bipolar illness (SMD\u2009=\u2009\u22120.31; 95% CI: \u22120.45, \u22120.16), CGI-BP-S bipolar depression (SMD\u2009=\u2009\u22120.33; 95% CI: \u22120.48, \u22120.17), quality of life (SMD\u2009=\u20090.22; 95% CI: 0.07, 0.36), and responder rate (RR\u2009=\u20091.27; 95% CI: 1.05, 1.53), but not remitter rate (1.06; 95% CI: 0.81, 1.38). Compared with placebo, discontinuation due to AE significantly increased at the 42\u2009mg dose (RR\u2009=\u20093.12; 95% CI: 1.68, 5.80), but not at 28\u2009mg (1.58; 95% CI: 0.25, 9.89). Moreover, dropout rates (42\u2009mg RR\u2009=\u20091.15; 95% CI: 0.76, 1.73) and other safety outcomes did not exhibit a dose\u2013response trend.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Preliminary evidence suggests that 42\u2009mg daily of lumateperone may provide clinical benefit in bipolar depression, yet the higher rate of AE-related discontinuation warrants caution in practice. However, current data remain limited, requiring further studies to establish the optimal dosing range balancing efficacy and safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811251364389","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:56:43Z","timestamp":1756385803000},"page":"1176-1183","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Dose-response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials"],"prefix":"10.1177","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8650-4060","authenticated-orcid":false,"given":"Chih-Wei","family":"Hsu","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Kang","family":"Tu","sequence":"additional","affiliation":[{"name":"Institute of Health Data Analytics and Statistics, College of Public Health, National Taiwan University, Taipei, Taiwan"},{"name":"Health Data Research Center, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chuan","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1138-5586","authenticated-orcid":false,"given":"Chih-Sung","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Beitou Branch, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"},{"name":"Department of Psychiatry, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Tao","family":"Tseng","sequence":"additional","affiliation":[{"name":"Prospect Clinic for Otorhinolaryngology and Neurology, Kaohsiung, Taiwan"},{"name":"Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan"},{"name":"Department of Psychology, College of Medical and Health Science, Asia University, Taichung, Taiwan"},{"name":"Institute of Precision Medicine, National Sun Yat-Sen University, Kaohsiung City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0622-9175","authenticated-orcid":false,"given":"Yang-Chieh Brian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2023.2236795"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01271-6"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2021.20091339"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1906193"},{"key":"e_1_3_3_6_1","unstructured":"ClinicalTrials.gov (2015) Clinical Trial Evaluating ITI-007 (lumateperone) as a monotherapy for the treatment of bipolar depression. Available at: https:\/\/clinicaltrials.gov\/study\/NCT02600494 (accessed 7 January 2025)."},{"key":"e_1_3_3_7_1","unstructured":"ClinicalTrials.gov (2020) Clinical trial evaluating lumateperone monotherapy in the treatment of bipolar depression or major depressive disorder. https:\/\/clinicaltrials.gov\/study\/NCT04285515 (accessed 7 January 2025)."},{"key":"e_1_3_3_8_1","unstructured":"ClinicalTrials.gov (2024) Multicenter study of lumateperone for the treatment of bipolar depression in pediatric patients. Available at: https:\/\/clinicaltrials.gov\/study\/NCT06372964 (accessed 7 January 2025)."},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/0962280218773122"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2016.1174577"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.260281"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3841"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00395-3"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028020936597"},{"key":"e_1_3_3_15_1","unstructured":"Higgins JP Thomas J Chandler J et al. (2024) Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane. Available at: https:\/\/training.cochrane.org\/handbook (accessed August 2024)."},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(23)00255-9"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.4265"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01872-x"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjment-2024-301165"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102308"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31544-0"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.18588"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/1536867X0600600103"},{"key":"e_1_3_3_24_1","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 372: n71.","journal-title":"BMJ"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyae052"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.4103\/ds.DS-D-22-00154"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3704-1"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413289"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.13310"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2022.06.009"},{"key":"e_1_3_3_31_1","unstructured":"U.S. Food and Drug Administration (2021) Center for Drug Evaluation and Research. Available at: https:\/\/www.fda.gov\/about-fda\/fda-organization\/center-drug-evaluation-and-research-cder (accessed 14 January 2025)."},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.24844"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12609"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(23)00199-2"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.45885"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251364389","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811251364389","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251364389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:12:23Z","timestamp":1777507943000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811251364389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1177\/02698811251364389"],"URL":"https:\/\/doi.org\/10.1177\/02698811251364389","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]}}}